REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 174 filers reported holding REATA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $11,676,459 | +133.7% | 114,520 | +108.4% | 0.10% | +108.3% |
Q1 2023 | $4,997,235 | -49.9% | 54,963 | -79.1% | 0.05% | -42.2% |
Q4 2022 | $9,976,326 | +35.2% | 262,604 | -10.5% | 0.08% | +33.9% |
Q3 2022 | $7,377,000 | +386.3% | 293,500 | +533.9% | 0.06% | +342.9% |
Q1 2022 | $1,517,000 | -43.8% | 46,300 | +167.6% | 0.01% | -61.1% |
Q2 2020 | $2,700,000 | +157.1% | 17,300 | +137.8% | 0.04% | -45.5% |
Q1 2020 | $1,050,000 | -70.8% | 7,275 | -58.6% | 0.07% | -25.0% |
Q4 2019 | $3,593,000 | +833.2% | 17,576 | +266.2% | 0.09% | +700.0% |
Q3 2019 | $385,000 | -51.4% | 4,800 | -42.9% | 0.01% | -60.7% |
Q2 2019 | $792,000 | -20.1% | 8,400 | -76.0% | 0.03% | -65.4% |
Q4 2017 | $991,000 | +27.4% | 35,000 | +40.0% | 0.08% | +14.1% |
Q3 2017 | $778,000 | – | 25,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |